Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Carnival Corp (CCL) vs Johnson & Johnson (JNJ) Price & Performance

Carnival CorpTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Carnival Corp vs Johnson & Johnson — how do they compare? Carnival Corp trades at $27.88 (market cap $37.98B), while Johnson & Johnson trades at $261.07 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 16.5× Carnival Corp's market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.

CCLJNJ
Market Cap
$37.98B$626.09B
Sector
Consumer CyclicalHealth
52-Week High
$33.99$267.24
52-Week Low
$23.89$172.78
Enterprise Value
$61.91B$654.37B
Dividend Yield
1.62%2.06%
Volume
6,156,228

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Carnival Corp

Carnival Corporation (CCL) trades at $27.82, showing modest daily gains of 0.25%. The stock maintains strong fundamental momentum with consecutive earnings beats in recent quarters (Q4 2025 and Q1 2026) and improving profitability trends. Technical indicators show a bearish bias in moving averages while oscillators remain neutral. The company demonstrates robust operational recovery with revenue growth from $12.2B in 2022 to $26.6B in 2025, and positive net cash flow of $727M in 2025 after years of negative cash flow.

CCL presents a compelling recovery story with analyst consensus pointing to 26% upside to the $35.18 price target. Investment opportunities include sustained travel demand, fleet expansion, and debt reduction progress. Key risks involve fuel price volatility, competitive pressures, and execution of growth initiatives amid economic uncertainty. The stock's attractive valuation (P/E 12.49x) and 59.6% analyst buy rating support a positive medium-term outlook.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.

Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Carnival Corp

Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.

Read more on CCL

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ